Chester County News and Community Website
HARRISBURG, PA — The American Lung Association Research Institute has opened its 2027-28 grant cycle to Pennsylvania researchers and other qualified scientists conducting U.S.-based studies, offering awards of up to …
Lung Association Opens 2027-28 Research Grant Cycle Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) secured patent protection in Europe and Australia through March 2041 for the liquid formulation of its investigational lung-disease therapy MOLBREEVI, expanding the intellectual-property …
Savara Extends MOLBREEVI Patent Protection to 2041 Read More
EXTON, PA — Lungpacer Medical Inc. said a study involving 50 organ donors found that temporary diaphragm neurostimulation improved donor lung function and increased the number of lungs available for …
Lungpacer Study Links Neurostimulation to Higher Lung Transplant Rates Read More LANGHORNE, PA — Savara (Nasdaq: SVRA) reported long-term Phase 3 trial data showing continued improvements in lung function and respiratory quality of life among patients receiving molgramostim for autoimmune pulmonary …
Savara Reports Long-Term Phase 3 Data Supporting Molgramostim Durability Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) said it has resubmitted its biologics license application for MOLBREEVI to the U.S. Food and Drug Administration, a key regulatory step toward approval …
FDA Clock Restarts: Savara Refiles MOLBREEVI for Rare Lung Disease Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the publication of a manuscript detailing long-term outcomes for molgramostim inhalation solution in patients with autoimmune pulmonary alveolar proteinosis (aPAP). The study, …
Savara Inc. Publishes Promising Long-Term Outcomes for aPAP Treatment Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has initiated the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI, a potential …
Savara Begins FDA Submission for Rare Lung Disease Treatment Read More